+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Dog Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type, Disease Type, Route Of Administration, Duration Of Immunity, Component, Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 115 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5914538
Description Jump to:
The global dog vaccine market size is anticipated to reach USD 2.6 billion by 2030 and display a CAGR of 6.0% during the forecast period, according to the report. The growth can be attributed to the increasing trend of pet humanization, pet ownership among millennials, and rising consciousness regarding preventive healthcare. According to Boehringer Ingelheim International GmbH, 35% of millennials and 32% of baby boomers own a pet. In addition, the rise in pet spending and insurance is also expected to add to the growth of this market. According to an article published by WorldAnimalFoundation.org in February 2023, dog owners spent approximately USD 570 more than cat owners.

Moreover, the increasing pet population, rising income levels in emerging markets of Asia-Pacific, such as China and India, and consequent changes in the lifestyle of people are expected to impact the growth of the dog vaccine industry significantly. For instance, according to an article published by the Economic Times in July 2023, the per capita income in India is expected to increase by 1.6 times to reach USD 4000 by 2030.

Dog Vaccine Market Report Highlights

  • Based on vaccine type, the modified/attenuated live vaccine segment accounted for the largest revenue share of 52.4% in 2022, as they help prevent disease and provide long-term immunity
  • Based on disease type, the canine rabies segment is expected to grow at the fastest CAGR of 6.9% over the forecast period due to the high prevalence of this disease and its zoonotic potential
  • Based on route of administration, the injectable segment accounted for the largest revenue share of 76.1% in 2022, owing to their convenience and ability to administer accurate dosage amounts
  • Based on duration of immunity, the 1-year segment dominated the market with a share of 51.2% in 2022 owing to their convenience
  • Based on component, the combined vaccines segment accounted for the largest market share of 65.5%. It is expected to grow at the fastest CAGR of 6.2% over the forecast period due to its ability to protect against more than one disease
  • North America dominated with a share of 38.8% in 2022, owing to the presence of major players and increasing awareness regarding preventive healthcare for pets. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR of 7.0% over the forecast period due to untapped opportunities in the emerging economies of China and India


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Vaccine type
1.1.2. Disease type
1.1.3. Route of administration
1.1.4. Duration of immunity
1.1.5. Component
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Vaccine type outlook
2.2.2. Disease type outlook
2.2.3. Route of administration outlook
2.2.4. Duration of immunity outlook
2.2.5. Component outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Dog Vaccine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Dog Vaccine Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Dog Vaccine: Vaccine Type Estimates & Trend Analysis
4.1. Dog Vaccine Market: Key Takeaways
4.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Modified/Attenuated Live
4.3.1. Modified/ attenuated live market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Inactivated (Killed)
4.4.1. Inactivated (Killed) market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Others
4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Dog Vaccine: Disease Type Estimates & Trend Analysis
5.1. Dog Vaccine Market: Key Takeaways
5.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Canine Distemper
5.3.1. Canine distemper market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Canine Infectious Respiratory Disease Complex (CIRDC)
5.4.1. Canine infectious respiratory disease complex (CIRDC) market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Canine Parvovirosis/ Parvovirus Disease
5.5.1. Canine parvovirosis/ parvovirus disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Canine Leptospirosis
5.6.1. Canine leptospirosis market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Canine Lyme Disease
5.7.1. Canine lyme disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Infectious Canine Hepatitis
5.8.1. Infectious canine hepatitis market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Canine Rabies
5.9.1. Canine distemper market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Other Diseases
5.10.1. Other diseases market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Dog Vaccine: Route of Administration Estimates & Trend Analysis
6.1. Dog Vaccine Market: Key Takeaways
6.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Injectable
6.3.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Intranasal
6.4.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Oral
6.5.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Dog Vaccine: Duration of Immunity Estimates & Trend Analysis
7.1. Dog Vaccine Market: Key Takeaways
7.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
7.3. 1 Year
7.3.1. 1-year market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. 3 Year
7.4.1. 3-year market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Others
7.5.1. others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Dog Vaccine: Component Estimates & Trend Analysis
8.1. Dog Vaccine Market: Key Takeaways
8.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
8.3. Combined Vaccines
8.3.1. Combined vaccines market estimates and forecasts, 2018 to 2030 (USD Million)
8.4. Mono Vaccines
8.4.1. Mono vaccines market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. Dog Vaccine Market: Regional Estimates & Trend Analysis
9.1. Regional Outlook
9.2. Dog Vaccine Market by Region: Key Takeaways
9.3. North America
9.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework/reimbursement structure
9.3.2.3. Competitive scenario
9.3.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.3.3. Canada
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework/reimbursement structure
9.3.3.3. Competitive scenario
9.3.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4. Europe
9.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.2. UK
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework/reimbursement structure
9.4.2.3. Competitive scenario
9.4.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.3. Germany
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework/reimbursement structure
9.4.3.3. Competitive scenario
9.4.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.4. France
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework/reimbursement structure
9.4.4.3. Competitive scenario
9.4.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.5. Italy
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework/reimbursement structure
9.4.5.3. Competitive scenario
9.4.5.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.6. Spain
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework/reimbursement structure
9.4.6.3. Competitive scenario
9.4.6.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.7. Denmark
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework/reimbursement structure
9.4.7.3. Competitive scenario
9.4.7.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.8. Sweden
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework/reimbursement structure
9.4.8.3. Competitive scenario
9.4.8.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4.9. Norway
9.4.9.1. Key country dynamics
9.4.9.2. Regulatory framework/reimbursement structure
9.4.9.3. Competitive scenario
9.4.9.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework/reimbursement structure
9.5.4.3. Competitive scenario
9.5.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.5. Thailand
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework/reimbursement structure
9.5.5.3. Competitive scenario
9.5.5.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5.6. South Korea
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework/reimbursement structure
9.5.6.3. Competitive scenario
9.5.6.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6.2. Mexico
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6.3. Argentina
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Market Participant Categorization
10.2.1. Bioveta, a.s.
10.2.1.1. Company overview
10.2.1.2. Financial performance
10.2.1.3. Product benchmarking
10.2.1.4. Strategic initiatives
10.2.2. HESTER BIOSCIENCES LIMITED
10.2.2.1. Company overview
10.2.2.2. Financial performance
10.2.2.3. Product benchmarking
10.2.2.4. Strategic initiatives
10.2.3. Boehringer Ingelheim International GmbH
10.2.3.1. Company overview
10.2.3.2. Financial performance
10.2.3.3. Product benchmarking
10.2.3.4. Strategic initiatives
10.2.4. Brilliant Bio Pharma
10.2.4.1. Company overview
10.2.4.2. Financial performance
10.2.4.3. Product benchmarking
10.2.4.4. Strategic initiatives
10.2.5. Heska Corporation
10.2.5.1. Company overview
10.2.5.2. Financial performance
10.2.5.3. Product benchmarking
10.2.5.4. Strategic initiatives
10.2.6. Merck & Co., Inc.
10.2.6.1. Company overview
10.2.6.2. Financial performance
10.2.6.3. Product benchmarking
10.2.6.4. Strategic initiatives
10.2.7. Virbac
10.2.7.1. Company overview
10.2.7.2. Financial performance
10.2.7.3. Product benchmarking
10.2.7.4. Strategic initiatives
10.2.8. Zendal group
10.2.8.1. Company overview
10.2.8.2. Financial performance
10.2.8.3. Product benchmarking
10.2.8.4. Strategic initiatives
10.2.9. Elanco
10.2.9.1. Company overview
10.2.9.2. Financial performance
10.2.9.3. Product benchmarking
10.2.9.4. Strategic initiatives
10.2.10. Zoetis Services LLC
10.2.10.1. Company overview
10.2.10.2. Financial performance
10.2.10.3. Product benchmarking
10.2.10.4. Strategic initiatives
List of Tables
1. List of abbreviations
2. North America dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
3. North America dog vaccine market, by disease type, 2018 - 2030 (USD Million)
4. North America dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
5. North America dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
6. North America dog vaccine market, by component, 2018 - 2030 (USD Million)
7. North America dog vaccine market, by region, 2018 - 2030 (USD Million)
8. U.S. dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
9. U.S. dog vaccine market, by disease type, 2018 - 2030 (USD Million)
10. U.S. dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
11. U.S. dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
12. U.S. dog vaccine market, by component, 2018 - 2030 (USD Million)
13. Canada dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
14. Canada dog vaccine market, by disease type, 2018 - 2030 (USD Million)
15. Canada dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
16. Canada dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
17. Canada dog vaccine market, by component, 2018 - 2030 (USD Million)
18. Europe dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
19. Europe dog vaccine market, by disease type, 2018 - 2030 (USD Million)
20. Europe dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
21. Europe dog vaccine market, by duration of immunity type, 2018 - 2030 (USD Million)
22. Europe dog vaccine market, by component type, 2018 - 2030 (USD Million)
23. Europe dog vaccine market, by region, 2018 - 2030 (USD Million)
24. UK dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
25. UK dog vaccine market, by disease type, 2018 - 2030 (USD Million)
26. UK dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
27. UK dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
28. UK dog vaccine market, by component, 2018 - 2030 (USD Million)
29. Germany dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
30. Germany dog vaccine market, by disease type, 2018 - 2030 (USD Million)
31. Germany dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
32. Germany dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
33. Germany Dog Vaccine market, by component, 2018 - 2030 (USD Million)
34. France dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
35. France dog vaccine market, by disease type, 2018 - 2030 (USD Million)
36. France dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
37. France dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
38. Italy dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
39. Italy dog vaccine market, by disease type, 2018 - 2030 (USD Million)
40. Italy dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
41. Italy dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
42. Italy dog vaccine market, by component, 2018 - 2030 (USD Million)
43. Spain dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
44. Spain dog vaccine market, by disease type, 2018 - 2030 (USD Million)
45. Spain dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
46. Spain dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
47. Spain dog vaccine market, by component, 2018 - 2030 (USD Million)
48. Sweden dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
49. Sweden dog vaccine market, by disease type, 2018 - 2030 (USD Million)
50. Sweden dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
51. Sweden dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
52. Sweden dog vaccine market, by component, 2018 - 2030 (USD Million)
53. Norway dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
54. Norway dog vaccine market, by disease type, 2018 - 2030 (USD Million)
55. Norway dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
56. Norway pain dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
57. Norway dog vaccine market, by component, 2018 - 2030 (USD Million)
58. Denmark dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
59. Denmark dog vaccine market, by disease type, 2018 - 2030 (USD Million)
60. Denmark dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
61. Denmark dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
62. Denmark dog vaccine market, by component, 2018 - 2030 (USD Million)
63. Asia-Pacific dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
64. Asia-Pacific dog vaccine market, by disease type, 2018 - 2030 (USD Million)
65. Asia-Pacific dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
66. Asia-Pacific dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
67. Asia-Pacific dog vaccine market, by component, 2018 - 2030 (USD Million)
68. Asia pacific dog vaccine market, by region, 2018 - 2030 (USD Million)
69. Japan dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
70. Japan dog vaccine market, by disease type, 2018 - 2030 (USD Million)
71. Japan dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
72. Japan dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
73. Japan dog vaccine market, by component, 2018 - 2030 (USD Million)
74. China dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
75. China dog vaccine market, by disease type, 2018 - 2030 (USD Million)
76. China dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
77. China dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
78. China dog vaccine market, by component, 2018 - 2030 (USD Million)
79. India dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
80. India dog vaccine market, by disease type, 2018 - 2030 (USD Million)
81. India dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
82. India dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
83. India dog vaccine market, by component, 2018 - 2030 (USD Million)
84. Australia dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
85. Australia dog vaccine market, by disease type, 2018 - 2030 (USD Million)
86. Australia dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
87. Australia dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
88. Australia dog vaccine market, by component, 2018 - 2030 (USD Million)
89. Thailand dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
90. Thailand dog vaccine market, by disease type, 2018 - 2030 (USD Million)
91. Thailand dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
92. Thailand dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
93. Thailand dog vaccine market, by component, 2018 - 2030 (USD Million)
94. South Korea dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
95. South Korea dog vaccine market, by disease type, 2018 - 2030 (USD Million)
96. South Korea dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
97. South Korea dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
98. South Korea dog vaccine market, by component, 2018 - 2030 (USD Million)
99. Latin America dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
100. Latin America dog vaccine market, by disease type, 2018 - 2030 (USD Million)
101. Latin America dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
102. Latin America dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
103. Latin America dog vaccine market, by component, 2018 - 2030 (USD Million)
104. Latin America Dog Vaccine market, by region, 2018 - 2030 (USD Million)
105. Brazil dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
106. Brazil dog vaccine market, by disease type, 2018 - 2030 (USD Million)
107. Brazil dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
108. Brazil dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
109. Brazil dog vaccine market, by component, 2018 - 2030 (USD Million)
110. Mexico dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
111. Mexico dog vaccine market, by disease type, 2018 - 2030 (USD Million)
112. Mexico dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
113. Mexico dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
114. Mexico dog vaccine market, by component, 2018 - 2030 (USD Million)
115. Argentina dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
116. Argentina dog vaccine market, by disease type, 2018 - 2030 (USD Million)
117. Argentina dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
118. Argentina dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
119. Argentina dog vaccine market, by component, 2018 - 2030 (USD Million)
120. Middle East and Africa dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
121. Middle East and Africa dog vaccine market, by disease type, 2018 - 2030 (USD Million)
122. Middle East and Africa dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
123. Middle East and Africa dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
124. Middle East and Africa dog vaccine market, by component, 2018 - 2030 (USD Million)
125. Middle East and Africa Dog Vaccine market, by region, 2018 - 2030 (USD Million)
126. South Africa dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
127. South Africa dog vaccine market, by disease type, 2018 - 2030 (USD Million)
128. South Africa dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
129. South Africa dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
130. South Africa dog vaccine market, by component, 2018 - 2030 (USD Million)
131. Saudi Arabia dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
132. Saudi Arabia dog vaccine market, by disease type, 2018 - 2030 (USD Million)
133. Saudi Arabia dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
134. Saudi Arabia dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
135. Saudi Arabia dog vaccine market, by component, 2018 - 2030 (USD Million)
136. UAE dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
137. UAE dog vaccine market, by disease type, 2018 - 2030 (USD Million)
138. UAE dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
139. UAE dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
140. UAE dog vaccine market, by component, 2018 - 2030 (USD Million)
141. Kuwait dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
142. Kuwait dog vaccine market, by disease type, 2018 - 2030 (USD Million)]
143. Kuwait dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
144. Kuwait dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
145. Kuwait dog vaccine market, by component, 2018 - 2030 (USD Million)
List of Figures
List of Figure
1. Market research process
2. Data triangulation techniques
3. Primary research pattern
4. Market research approaches
5. QFD modeling for market share assessment
6. Market formulation & validation
7. Dog Vaccines: Market outlook
8. Dog Vaccines: Competitive insights
9. Parent market outlook
10. Related/ancillary market outlook
11. Penetration and growth prospect mapping
12. Industry value chain analysis
13. Dog vaccine market driver impact
14. Dog vaccine market restraint impact
15. Dog vaccine market strategic initiatives analysis
16. Dog vaccine market: Vaccine type movement analysis
17. Dog vaccine market: Vaccine type outlook and key takeaways
18. Modified/ attenuated live market estimates and forecasts, 2018 - 2030
19. Inactivated (Killed) market estimates and forecasts, 2018 - 2030
20. Others market estimates and forecasts, 2018 - 2030
21. Dog vaccine market: Disease type movement analysis
22. Dog vaccine market: Disease type outlook and key takeaways
23. Canine distemper market estimates and forecasts, 2018 - 2030
24. Canine infectious respiratory disease complex (CIRDC)market estimates and forecasts, 2018 - 2030
25. Canine parvovirosis/ parvovirus disease market estimates and forecasts, 2018 - 2030
26. Canine Lyme disease market estimates and forecasts, 2018 - 2030
27. Infectious canine hepatitis market estimates and forecasts, 2018 - 2030
28. Canine rabies market estimates and forecasts, 2018 - 2030
29. Other diseases market estimates and forecasts, 2018 - 2030
30. Dog Vaccine market: Route of administration movement analysis
31. Dog Vaccine market: Route of administration outlook and key takeaways
32. Injectable market estimates and forecasts, 2018 - 2030
33. Intranasal market estimates and forecasts, 2018 - 2030
34. Oral market estimates and forecasts, 2018 - 2030
35. Dog Vaccine market: Duration of immunity movement analysis
36. Dog Vaccine market: Duration of immunity outlook and key takeaways
37. 1 year market estimates and forecasts, 2018 - 2030
38. 3-year market estimates and forecasts, 2018 - 2030
39. others market estimates and forecasts, 2018 - 2030
40. Dog Vaccine market: Component movement analysis
41. Dog Vaccine market: Component of immunity outlook and key takeaways
42. Combined vaccines market estimates and forecasts, 2018 - 2030
43. Mono vaccines market estimates and forecasts, 2018 - 2030
44. Global dog vaccine market: Regional movement analysis
45. Global dog vaccine market: Regional outlook and key takeaways
46. North America market estimates and forecasts, 2018 - 2030
47. U.S. market estimates and forecasts, 2018 - 2030
48. Canada market estimates and forecasts, 2018 - 2030
49. Europe market estimates and forecasts, 2018 - 2030
50. UK market estimates and forecasts, 2018 - 2030
51. Germany market estimates and forecasts, 2018 - 2030
52. France market estimates and forecasts, 2018 - 2030
53. Italy market estimates and forecasts, 2018 - 2030
54. Spain market estimates and forecasts, 2018 - 2030
55. Denmark market estimates and forecasts, 2018 - 2030
56. Sweden market estimates and forecasts, 2018 - 2030
57. Norway market estimates and forecasts, 2018 - 2030
58. Asia Pacific market estimates and forecasts, 2018 - 2030
59. Japan market estimates and forecasts, 2018 - 2030
60. China market estimates and forecasts, 2018 - 2030
61. India market estimates and forecasts, 2018 - 2030
62. Australia market estimates and forecasts, 2018 - 2030
63. Thailand market estimates and forecasts, 2018 - 2030
64. South Korea market estimates and forecasts, 2018 - 2030
65. Latin America market estimates and forecasts, 2018 - 2030
66. Brazil market estimates and forecasts, 2018 - 2030
67. Mexico market estimates and forecasts, 2018 - 2030
68. Argentina market estimates and forecasts, 2018 - 2030
69. Middle East and Africa. market estimates and forecasts, 2018 - 2030
70. Saudi Arabia market estimates and forecasts, 2018 - 2030
71. South Africa market estimates and forecasts, 2018 - 2030
72. UAE market estimates and forecasts, 2018 - 2030
73. Kuwait market estimates and forecasts, 2018 - 2030

Companies Profiled

  • Bioveta, a.s.
  • HESTER BIOSCIENCES LIMITED
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma
  • Heska Corporation
  • Merck & Co., Inc.
  • Virbac
  • Zendal group
  • Elanco
  • Zoetis Services LLC

Methodology

Loading
LOADING...

Related Topics

Related Reports

Dog Vaccines Global Market Report 2024 - Product Image

Dog Vaccines Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Canine Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Image

Canine Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 84 Pages
  • Global
From
Companion Animal Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Companion Animal Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 114 Pages
  • Global
From
Veterinary Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Veterinary Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 114 Pages
  • Global
From
Global Veterinary Medicine Market Size, Share & Trends Analysis Report by Product (Biologics, Pharmaceuticals, Medicated Feed Additives), Animal Type, Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Veterinary Medicine Market Size, Share & Trends Analysis Report by Product (Biologics, Pharmaceuticals, Medicated Feed Additives), Animal Type, Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 200 Pages
  • Global
From

About the Canine Vaccine Market

The Canine Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for dogs. Vaccines are used to protect dogs from a variety of diseases, including rabies, distemper, parvovirus, and leptospirosis. Vaccines are typically administered by veterinarians, and may be given as a single dose or as a series of doses. Vaccines are also available in a variety of forms, including injectable, oral, and intranasal. In addition to vaccines, the Canine Vaccine market also includes products such as flea and tick control, heartworm prevention, and other health-related products. These products are designed to help keep dogs healthy and reduce the risk of disease. Some of the companies in the Canine Vaccine market include Merck Animal Health, Zoetis, Elanco, Boehringer Ingelheim, and Virbac. These companies produce a variety of vaccines and other products for dogs, and are committed to providing quality products to pet owners. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.